HOME >> MEDICINE >> NEWS
Key industry players meet at the European Parliament's Life Science Circle

Brussels: The benefits of direct access to patient information will be a main theme of the European Life Science Circle (ELSC) which will be held in Brussels on 12 September 2006. "The European health system faces many new challenges. Patients are more involved, want more information and have a greater say in their own well-being", said Dr. Jorgo Chatzimarkakis, German Member of the European Parliament and the founder of the Parliament's Life Science Circle.

The keynote presentation will be by Prof. Dr. Harms President of the European Health Care Foundation, who will share his thoughts and experiences on direct access to patient information. Mrs. Lalis, from the European Commission's DG Enterprise, European Commission will respond. Mr. Chatzimarkakis will introduce the discussion.

The Life Science Circle is intended to be a policy platform to discuss reform of Europe's health care system. It will also be the forum for the discussion of improved patient conditions in Europe. The main objective of the Circle is thus to bring the EU life science sector forward and turn Europe into the world's 'bio-zone', according to Dr. Chatzimarkakis.

The ELSC offers the opportunity to shape the debates in a number of areas including health system infrastructure, preventive medicine, e-health, research and innovation, patents, improved quality in health care giving legislators, decision-makers, stakeholders, patients associations, researchers and industry representatives the chance to influence important developments.

Participation in the Life Sciences Circle is by invitation only.


'"/>

Contact: Declan Kirrane
dk@isc-europe.com
32-024-016-144
ISC
30-Aug-2006


Page: 1

Related medicine news :

1. Advocates ask fashion industry to support braille clothing tags; talking Web site
2. Navigating legal minefields of drug industry addressed at UH talk
3. Positive results more likely from industry-funded breast cancer trials
4. FDAs modern risk-based approach opens dialogue with industry
5. Lessons from Vioxx case -- New approach needed to restore faith in pharmaceutical industry
6. New agreement questions NHS relation with industry
7. Dedicated R&D lab established to spur RFID industry in Canada
8. Living close to heavy industry may increase risk of lung cancer
9. Consumer hygiene fears keep food industry on its toes
10. Pharmaceutical industry welcomes Labor Partys Innovation Blueprint
11. Policy changes in poultry industry could reduce worker injuries, report suggests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... Compliance and Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual ... Innovation to Action Award. , The Innovation to Action Award, a USAID ...
(Date:9/19/2017)... ... 2017 , ... MelaKids, a Laredo-based company, has introduced a new concept for ... Nature gives us a full supply of melanin – in the back of the ... glare-reducing pigment; however, around the age of thirty, we develop a yellow-brown pigment in ...
(Date:9/19/2017)... ... 19, 2017 , ... The Workgroup for Electronic Data Interchange (WEDI) , ... in healthcare information exchange and a trusted advisor to the U.S. Department of Health ... entitled Barriers to Adoption of the ERA and EFT Transactions . , ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the ... industry itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. ... natural alkaline water technologies, water filtration systems, and consumer education. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone ... the first in the U.S. to incorporate magnesium, a critical property for bone ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)...  Medical professionals are expected to continuously ... their patients. Medical simulations offer clinicians the ... Simulation provides a safe method for teaching ... refine techniques and build confidence, without putting ... such as augmented reality, will now provide ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
Breaking Medicine Technology:
Cached News: